1. Home
  2. KALU vs NVAX Comparison

KALU vs NVAX Comparison

Compare KALU & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kaiser Aluminum Corporation

KALU

Kaiser Aluminum Corporation

HOLD

Current Price

$130.72

Market Cap

1.9B

Sector

Industrials

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.03

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALU
NVAX
Founded
1946
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.6B
IPO Year
2006
1996

Fundamental Metrics

Financial Performance
Metric
KALU
NVAX
Price
$130.72
$8.03
Analyst Decision
Buy
Hold
Analyst Count
3
9
Target Price
$107.00
$11.33
AVG Volume (30 Days)
166.3K
3.7M
Earning Date
04-22-2026
05-07-2026
Dividend Yield
2.56%
N/A
EPS Growth
135.89
309.76
EPS
6.77
2.58
Revenue
$1,585,900,000.00
$1,123,479,000.00
Revenue This Year
$13.37
N/A
Revenue Next Year
$2.62
N/A
P/E Ratio
$17.83
$3.16
Revenue Growth
N/A
64.69
52 Week Low
$46.81
$5.01
52 Week High
$150.00
$11.85

Technical Indicators

Market Signals
Indicator
KALU
NVAX
Relative Strength Index (RSI) 59.99 34.64
Support Level $116.89 $8.01
Resistance Level $136.10 $8.45
Average True Range (ATR) 5.10 0.55
MACD 1.43 -0.28
Stochastic Oscillator 99.08 9.93

Price Performance

Historical Comparison
KALU
NVAX

About KALU Kaiser Aluminum Corporation

Kaiser Aluminum Corp specializes in the production of semi-fabricated specialty aluminum mill products, such as aluminum plate and sheet, bare and coated coil and extruded and drawn products, for the end market applications: Aero/HS Products; Packaging; GE Products; and Automotive Extrusions. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from the United States.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: